Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Biochim Biophys Acta Mol Basis Dis ; 1864(1): 296-306, 2018 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-29107807

RESUMO

The RNA-binding protein, HuR, modulates mRNA processing and gene expression of several stress response proteins i.e. Hsp70 and p53 that have been postulated to be involved in the pathogenesis of glaucoma, a chronic optic neuropathy leading to irreversible blindness. We evaluated HuR protein expression in retinas and optic nerves of glaucomatous rats and human primary open angle glaucoma patients and its possible impact on stress response mechanisms. We found that the cytoplasmic content of HuR was reduced more extensively in glaucomatous retinas than in optic nerves and this was linked with a declined cytoplasmic Hsp70 level and p53 nuclear translocation. In the optic nerve, the p53 content was decreased as a feature of reactive gliosis. Based on our findings, we conclude that the alteration in the HuR content, observed both in rat glaucoma model and human glaucoma samples, affects post-transcriptionally the expression of genes crucial for maintaining cell homeostasis; therefore, we postulate that HuR may be involved in the pathogenesis of glaucoma.


Assuntos
Proteína Semelhante a ELAV 1/metabolismo , Hipertensão Ocular/metabolismo , Células Ganglionares da Retina/metabolismo , Animais , Estudos de Casos e Controles , Modelos Animais de Doenças , Proteína Semelhante a ELAV 1/genética , Glaucoma de Ângulo Aberto/genética , Glaucoma de Ângulo Aberto/metabolismo , Glaucoma de Ângulo Aberto/patologia , Humanos , Pressão Intraocular/genética , Masculino , Neuroproteção/genética , Hipertensão Ocular/genética , Hipertensão Ocular/patologia , Nervo Óptico/metabolismo , Nervo Óptico/patologia , Ratos , Ratos Wistar , Células Ganglionares da Retina/patologia , Distribuição Tecidual
2.
Acta Ophthalmol ; 98(4): 408-417, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-31602808

RESUMO

PURPOSE: To characterize newly discovered electrical synapses, formed by connexin (Cx) 36 and 45, between neighbouring axons within the optic nerve head. METHODS: Twenty-five Wistar rats were killed by CO2 inhalation. Proximal and distal optic nerve (ON) stumps were collected and processed for immunostainings, electron microscopy (EM) with immunogold labelling, PCR and Western blots (WB). Additional 15 animals were deeply anaesthetized, and flash visual evoked potentials (fVEP) after retrobulbar injection of saline (negative control) or 100 µm meclofenamic acid solution (gap junctions' blocker) were recorded. Human paraffin cross-sections of eyeballs for immunostainings were obtained from the Human Eye Biobank for Research. RESULTS: Immunostainings of both rat and human ON revealed the presence of Cx45 and 36 colocalizing with ß3-tubulin, but not with glial fibrillary acidic protein (GFAP). In WB, Cx36 content in optic nerve was approximately halved when compared with retina (0.58 ± 0.005 in proximal stump and 0.44 ± 0.02 in distal stump), Cx45 showed higher levels (0.68 ± 0.01 in proximal stump and 0.9 ± 0.07 in distal stump). In immunogold-EM of optic nerve sections, we found electric synapses (formed mostly by Cx45) directly coupling neighbouring axons. In fVEP, blocking of gap junctions with meclofenamic acid resulted in significant prolongation of the latency of P1 wave up to 160% after 30 min (p < 0.001). CONCLUSIONS: Optic nerve (ON) axons are equipped with electrical synapses composed of neuronal connexins, especially Cx45, creating direct morphological and functional connections between each other. This finding could have substantial implications for understanding of the pathogenesis of various optic neuropathies and identifies a new potential target for a therapeutic approach.


Assuntos
Sinapses Elétricas/fisiologia , Potenciais Evocados Visuais/fisiologia , Junções Comunicantes/metabolismo , Disco Óptico/fisiologia , Animais , Axônios/metabolismo , Axônios/ultraestrutura , Western Blotting , Junções Comunicantes/ultraestrutura , Humanos , Masculino , Microscopia Eletrônica , Modelos Animais , Neurônios/metabolismo , Neurônios/ultraestrutura , Disco Óptico/metabolismo , Disco Óptico/ultraestrutura , Ratos , Ratos Wistar
3.
Eur J Pharmacol ; 788: 12-20, 2016 Oct 05.
Artigo em Inglês | MEDLINE | ID: mdl-27288881

RESUMO

Success of the long-term glaucoma therapy and preservation of the visual function strongly depend on patients' compliance which may be affected by the inconvenience of treatment and its side effects. Recently, introduction of preservative-free anti-glaucoma agents has become an important step towards improved glaucoma care by eliminating the negative effects of preservatives on the eye surface. Although, newly developed eye drop formulations do not contain standard preservatives, they still can be harmful to ocular surface due to other excipients. In this study, we compared tolerability of commercial preservative-free (pf) prostaglandin analogues (pf tafluprost, pf latanoprost and pf bimatoprost) in long-term topical application in rabbits in vivo. We found that after eight weeks treatment, pf latanoprost was the worst tolerated among the tested drops. It expressed increased conjunctival redness and blinking frequency. Furthermore, it caused increased LDH release in the aqueous humour, infiltration of macrophages in the eyelids and visible defects in conjunctival goblet cells. However, we did not detect increased levels of inflammatory markers in the tear fluid or in the aqueous humour. Based on our study, we suspect that these negative effects are related to excipients included in pf latanoprost formulation.


Assuntos
Olho/efeitos dos fármacos , Olho/imunologia , Macrófagos/efeitos dos fármacos , Macrófagos/imunologia , Prostaglandinas Sintéticas/administração & dosagem , Prostaglandinas Sintéticas/efeitos adversos , Administração Tópica , Animais , Biomarcadores/metabolismo , Piscadela/efeitos dos fármacos , Núcleo Celular/efeitos dos fármacos , Túnica Conjuntiva/efeitos dos fármacos , Proteínas de Ligação a DNA/metabolismo , Olho/metabolismo , Pálpebras/citologia , Pálpebras/efeitos dos fármacos , Feminino , L-Lactato Desidrogenase/metabolismo , Conservantes Farmacêuticos , Prostaglandinas Sintéticas/química , Coelhos , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA